Patents by Inventor Andrew Patterson

Andrew Patterson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240105303
    Abstract: Described are systems and methods of predicting a response to a medical treatment in a subject. The systems and methods include the steps of selecting a set of mutations within at least one biological process, training a set of classifiers from the set of selected mutations via a training dataset, determining the performance level of each classifier via a validation dataset, applying a subset of high-performance level classifiers from the validation dataset via a test dataset, and predicting the response to the medical treatment based on the test dataset.
    Type: Application
    Filed: September 19, 2023
    Publication date: March 28, 2024
    Inventors: Noam Auslander, Andrew Patterson
  • Patent number: 11722101
    Abstract: Apparatus and methods for a modified Doherty amplifier operating at gigahertz frequencies are described. The combining of signals from a main amplifier and a peaking amplifier occur prior to impedance matching of the amplifier's output to a load. An output impedance-matching element can be relied upon. In one example, the output impedance-matching element can include an output strip line, a shunt capacitor connected between the output strip line and ground, an output capacitor connected between the output strip line and an output bonding pad, and an inductive strip line connected between the output bonding pad and ground.
    Type: Grant
    Filed: December 17, 2021
    Date of Patent: August 8, 2023
    Assignee: MACOM TECHNOLOGY SOLUTIONS HOLDINGS, INC.
    Inventors: Gerard Bouisse, Andrew Alexander, Andrew Patterson
  • Publication number: 20220109406
    Abstract: Apparatus and methods for a modified Doherty amplifier operating at gigahertz frequencies are described. The combining of signals from a main amplifier and a peaking amplifier occur prior to impedance matching of the amplifier's output to a load. An output impedance-matching element can be relied upon. In one example, the output impedance-matching element can include an output strip line, a shunt capacitor connected between the output strip line and ground, an output capacitor connected between the output strip line and an output bonding pad, and an inductive strip line connected between the output bonding pad and ground.
    Type: Application
    Filed: December 17, 2021
    Publication date: April 7, 2022
    Inventors: Gerard Bouisse, Andrew Alexander, Andrew Patterson
  • Patent number: 11233483
    Abstract: Apparatus and methods for a modified Doherty amplifier operating at gigahertz frequencies are described. The combining of signals from a main amplifier and a peaking amplifier occur prior to impedance matching of the amplifier's output to a load. An integrated distributed inductor may be used in an impedance inverter to combine the signals. A size of the impedance element can be selected by patterning during manufacture to tune the amplifier and to allow power scaling for the amplifier.
    Type: Grant
    Filed: August 2, 2019
    Date of Patent: January 25, 2022
    Assignee: MACOM TECHNOLOGY SOLUTIONS HOLDINGS, INC.
    Inventors: Gerard Bouisse, Andrew Alexander, Andrew Patterson
  • Patent number: 11008570
    Abstract: The disclosure relates to novel compounds and compositions comprising a RNAi agent comprising a novel compound as a 3? end cap. The disclosure also relates to processes for making such compositions, and methods and uses of such compositions, e.g., to mediate RNA interference.
    Type: Grant
    Filed: January 16, 2019
    Date of Patent: May 18, 2021
    Assignee: Novartis AG
    Inventors: Jeremy Lee Baryza, Marcel Blommers, Cesar Fernandez, Erin Geno, Alvar Gossert, Paulette Greenidge, Dieter Huesken, Juerg Hunziker, Francois Jean-Charles Natt, Anup Patnaik, Andrew Patterson, Jean-Michel Rene Rondeau, Jan Weiler, Meicheng Zhu
  • Patent number: 10756631
    Abstract: A multi-voltage converter is described that includes integrated temperature-protection circuitry. The converter may be used to bias radio-frequency components such as PIN diodes and gallium-nitride devices, and may include integrated bias-sequencing circuitry. Programmable output voltages as high as 30 volts and as low as ?20 volts may be generated.
    Type: Grant
    Filed: March 15, 2019
    Date of Patent: August 25, 2020
    Assignee: MACOM TECHNOLOGY SOLUTIONS HOLDINGS, INC.
    Inventors: Andrew Patterson, Brendan Foley, Michelle Dowling, Chi Mo
  • Publication number: 20200021195
    Abstract: A multi-voltage converter is described that includes integrated temperature-protection circuitry. The converter may be used to bias radio-frequency components such as PIN diodes and gallium-nitride devices, and may include integrated bias-sequencing circuitry. Programmable output voltages as high as 30 volts and as low as ?20 volts may be generated.
    Type: Application
    Filed: March 15, 2019
    Publication date: January 16, 2020
    Applicant: MACOM Technology Solutions Holdings, Inc.
    Inventors: Andrew Patterson, Brendan Foley, Michelle Dowling
  • Patent number: 10519446
    Abstract: The disclosure relates to compositions comprising a HBV RNAi agent. In some embodiments, the HBV RNAi agent comprises a sense and an anti-sense strand, each strand being an 18-mer and the strands together forming a blunt-ended duplex, wherein the 3? end of at least one strand terminates in a phosphate or modified internucleoside linker and further comprises, in 5? to 3? order: a spacer; a second phosphate or modified internucleoside linker; and a 3? end cap. In some embodiments, the 3? end of both the sense and anti-sense strand further comprise, in 5? to 3? order: a spacer; a second phosphate or modified internucleoside linker; and a 3? end cap. The two strands can have the same or different spacers, phosphates or modified internucleoside linkers, and/or 3? end caps. The strands can be ribonucleotides, or, optionally, one or more nucleotide can be modified or substituted. Optionally, at least one nucleotide comprises a modified internucleoside linker.
    Type: Grant
    Filed: September 30, 2014
    Date of Patent: December 31, 2019
    Assignee: NOVARTIS AG
    Inventors: Jeremy Lee Baryza, Marcel Blommers, Cesar Fernandez, Erin Geno, Alvar Gossert, Paulette Greenidge, Dieter Huesken, Juerg Hunziker, Francois Jean-Charles Natt, Anup Patnaik, Andrew Patterson, Jean-Michel Rene Rondeau, Jan Weiler, Meicheng Zhu, Meghan Holdorf
  • Publication number: 20190390196
    Abstract: The disclosure relates to novel compounds and compositions comprising a RNAi agent comprising a novel compound as a 3? end cap. The disclosure also relates to processes for making such compositions, and methods and uses of such compositions, e.g., to mediate RNA interference.
    Type: Application
    Filed: January 16, 2019
    Publication date: December 26, 2019
    Applicant: Novartis AG
    Inventors: Jeremy Lee Baryza, Marcel Blommers, Cesar Fernandez, Erin Geno, Alvar Gossert, Paulette Greenidge, Dieter Huesken, Juerg Hunziker, Francois Jean-Charles Natt, Anup Patnaik, Andrew Patterson, Jean-Michel Rene Rondeau, Jan Weiler, Meicheng Zhu
  • Publication number: 20190356277
    Abstract: Apparatus and methods for a modified Doherty amplifier operating at gigahertz frequencies are described. The combining of signals from a main amplifier and a peaking amplifier occur prior to impedance matching of the amplifier's output to a load. An integrated distributed inductor may be used in an impedance inverter to combine the signals. A size of the impedance element can be selected by patterning during manufacture to tune the amplifier and to allow power scaling for the amplifier.
    Type: Application
    Filed: August 2, 2019
    Publication date: November 21, 2019
    Applicant: MACOM Technology Solutions Holdings, Inc.
    Inventors: Gerard Bouisse, Andrew Alexander, Andrew Patterson
  • Patent number: 10227588
    Abstract: The disclosure relates to novel compounds and compositions comprising a RNAi agent comprising a novel compound as a 3? end cap. The disclosure also relates to processes for making such compositions, and methods and uses of such compositions, e.g., to mediate RNA interference.
    Type: Grant
    Filed: October 1, 2014
    Date of Patent: March 12, 2019
    Assignee: NOVARTIS AG
    Inventors: Jeremy Lee Baryza, Marcel Blommers, Cesar Fernandez, Erin Geno, Alvar Gossert, Paulette Greenidge, Dieter Huesken, Juerg Hunziker, Francois Jean-Charles Natt, Anup Patnaik, Andrew Patterson, Jean-Michel Rene Rondeau, Jan Weiler, Meicheng Zhu
  • Publication number: 20180358886
    Abstract: A multi-voltage converter is described that includes integrated temperature-protection circuity. The converter may be used to bias radio-frequency components such as PIN diodes and gallium-nitride devices, and may include integrated bias-sequencing circuitry. Programmable output voltages as high as 30 volts and as low as ?20 volts may be generated.
    Type: Application
    Filed: June 9, 2017
    Publication date: December 13, 2018
    Applicant: MACOM Technology Solution Holdings, Inc.
    Inventors: Andrew Patterson, Brendan Foley, Michelle Dowling
  • Patent number: 9988627
    Abstract: The disclosure relates to compositions comprising a RNAi agent having a novel format including a spacer subunit. The disclosure relates to compositions comprising a RNAi agent having a novel format: an 18-mer format with at least one internal spacer. These RNAi agents comprise a first and a second 18-mer strand, wherein the first strand is 18 ribonucleotides or 18 total ribonucleotides and spacer subunit(s), and the second strand is 18 total ribonucleotides and spacer subunit(s), wherein: each spacer subunit consists of: (a) a phosphate or modified internucleoside linker and (b) a spacer; a spacer subunit can be at any position in the strand; the two strands form a duplex with at least one blunt end; and the 3 end of one or both strands terminates in a phosphate or modified internucleoside linker and further comprises, in 5 to 3 order: a second spacer; a second phosphate or modified internucleoside linker, and a 3 end cap.
    Type: Grant
    Filed: October 6, 2014
    Date of Patent: June 5, 2018
    Assignee: NOVARTIS AG
    Inventors: Jeremy Lee Baryza, Marcel Blommers, William Chutkow, Cesar Fernandez, Erin Geno, Alvar Gossert, Paulette Greenidge, Dieter Huesken, Juerg Hunziker, Francois Jean-Charles Natt, Anup Patnaik, Andrew Patterson, Jean-Michel Rene Rondeau, Jan Weiler, Meicheng Zhu
  • Publication number: 20160304863
    Abstract: The disclosure relates to novel compounds and compositions comprising a RNAi agent comprising a novel compound as a 3? end cap. The disclosure also relates to processes for making such compositions, and methods and uses of such compositions, e.g., to mediate RNA interference.
    Type: Application
    Filed: October 1, 2014
    Publication date: October 20, 2016
    Inventors: Jeremy Lee BARYZA, Marcel BLOMMERS, Cesar FERNANDEZ, Erin GENO, Alvar GOSSERT, Paulette GREENIDGE, Dieter HUESKEN, Juerg HUNZIKER, Francois Jean-Charles NATT, Anup PATNAIK, Andrew PATTERSON, Jean-Michel Rene RONDEAU, Jan WEILER, Meicheng ZHU
  • Publication number: 20160247359
    Abstract: A wagering platform is described that generates one or more betting options and/or insurance to enable a bettor to modify his initial wager during a betting event such as, for example, a sporting event. The options can include, for example, allowing the bettor to double-down, to flip-flop, and/or to purchase bad-beat insurance. The platform can also include a locked-odds option to allow the bettor the option to place a wager at specified odds after the event has already started. Related apparatus, systems, techniques and articles are also described.
    Type: Application
    Filed: September 23, 2014
    Publication date: August 25, 2016
    Inventors: Martin De Knijff, Andrew Patterson
  • Publication number: 20160244756
    Abstract: The disclosure relates to compositions comprising a RNAi agent having a novel format including a spacer subunit. The disclosure relates to compositions comprising a RNAi agent having a novel format: an 18-mer format with at least one internal spacer. These RNAi agents comprise a first and a second 18-mer strand, wherein the first strand is 18 ribonucleotides or 18 total ribonucleotides and spacer subunit(s), and the second strand is 18 total ribonucleotides and spacer subunit(s), wherein: each spacer subunit consists of: (a) a phosphate or modified internucleoside linker and (b) a spacer; a spacer subunit can be at any position in the strand; the two strands form a duplex with at least one blunt end; and the 3 end of one or both strands terminates in a phosphate or modified internucleoside linker and further comprises, in 5 to 3 order: a second spacer; a second phosphate or modified internucleoside linker, and a 3 end cap.
    Type: Application
    Filed: October 6, 2014
    Publication date: August 25, 2016
    Inventors: Jeremy Lee BARYZA, Marcel BLOMMERS, William CHUTKOW, Cesar FERNANDEZ, Erin GENO, Alvar GOSSERT, Paulette GREENIDGE, Dieter HUESKEN, Juerg HUNZIKER, Francois Jean-Charles NATT, Anup PATNAIK, Andrew PATTERSON, Jean-Michel Rene RONDEAU, Jan WEILER, Meicheng ZHU
  • Publication number: 20160215288
    Abstract: The disclosure relates to compositions comprising a HBV RNAi agent. In some embodiments, the HBV RNAi agent comprises a sense and an anti-sense strand, each strand being an 18-mer and the strands together forming a blunt-ended duplex, wherein the 3? end of at least one strand terminates in a phosphate or modified internucleoside linker and further comprises, in 5? to 3? order: a spacer; a second phosphate or modified internucleoside linker; and a 3? end cap. In some embodiments, the 3? end of both the sense and anti-sense strand further comprise, in 5? to 3? order: a spacer; a second phosphate or modified internucleoside linker; and a 3? end cap. The two strands can have the same or different spacers, phosphates or modified internucleoside linkers, and/or 3? end caps. The strands can be ribonucleotides, or, optionally, one or more nucleotide can be modified or substituted. Optionally, at least one nucleotide comprises a modified internucleoside linker.
    Type: Application
    Filed: September 30, 2014
    Publication date: July 28, 2016
    Inventors: Jeremy Lee Baryza, Marcel Blommers, Cesar Femandez, Erin Geno, Alvar Gossert, Paulette Greenidge, Dieter Huesken, Juerg Hunziker, Francois Jean-Charles Natt, Anup Patnaik, Andrew Patterson, Jean-Michel Rene Rondeau, Jan Weiler, Meicheng zhu, Meghan Holdorf
  • Publication number: 20160217274
    Abstract: A data distribution system is provided which supplies customers with an executable for requested secured data files to provide the customer with fulfillment software, obviating the need for the customer to download fulfillment software prior to requesting secure data. The data distribution system is characterized by server technology which can dynamically encrypt secured data files just prior to a customer request to download the data file. A framework for building a universal data distribution infrastructure is provided which employs Requesters.
    Type: Application
    Filed: January 29, 2016
    Publication date: July 28, 2016
    Inventors: Shannon Lee BYRNE, Innes MUECKE, Andrew PATTERSON, David SLIK
  • Patent number: 9335931
    Abstract: A system and method for making snapshots of storage devices are provided. A method for making a snapshot of a volume includes setting the volume to a read-only mode, receiving an access attempt for the volume, and if the access attempt is a write access attempt, buffering information associated with the write access attempt in a buffer, and updating a snapshot indicator based on the information associated with the write access attempt, where the snapshot indicator includes block information regarding a block in the volume that is a target of the write access attempt. The method also includes if the access attempt is a read access attempt, providing read information requested in the read access attempt, where the read information is based on the volume, or a combination of the snapshot indicator, the buffer, and a buffer indicator.
    Type: Grant
    Filed: July 1, 2011
    Date of Patent: May 10, 2016
    Assignee: FUTUREWEI TECHNOLOGIES, INC.
    Inventors: Andrew Patterson, James Hughes, Hao Zhang
  • Patent number: 9063950
    Abstract: A method for enabling raster image editing software to work with geospatial imagery includes identifying geospatial metadata for an image upon opening of the image, and monitoring all raster image editing operations performed on the image to determine if the geospatial metadata is affected. The geospatial metadata is updated if the geospatial metadata is affected by a raster image editing operation. In another aspect, a computer readable medium contains instructions for controlling a computer system to perform a method for enabling raster image editing software to work with geospatial imagery.
    Type: Grant
    Filed: October 24, 2007
    Date of Patent: June 23, 2015
    Assignee: AVENZA SYSTEMS INC.
    Inventors: Edward Florence, Garvan Keeley, Ilya Varaev, Michael Yakubovsky, Andrew Patterson